Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met
Study met both co-primary endpoints with robust immune responses COVAXIN™ was found to be well-tolerated…
Veraify Launches Token Management to Help Enterprises Master AI “Tokenomics”
One Stop Systems Expands Enterprise AI Market Opportunity with Qualification for Tier 1 Global Computing Platform Provider